Antonia DePace

Antonia DePace, Editor for CURE®, has covered medical news for MJH Life Sciences, CURE®’s parent company, since 2021. She has written for EatingWell, Natural Awakenings Greater Boston, The Boston Globe and a variety of other lifestyle publications. She attended Emerson College, where she studied journalism and publishing. Antonia enjoys traveling, cooking, yoga and all things health and wellness. Follow her on Instagram @antonialdepace or email her at

Younger Children May Have Increased Risk for Hearing Loss From Chemotherapy

September 23, 2021

Children younger than five years old may have an increased risk for hearing loss from cisplatin-based therapies compared with older children, highlighting the potential need for more consistent monitoring for hearing loss in children with cancer.

FDA Approves Cabometyx For Thyroid Cancer Subset

September 22, 2021

The FDA approval of Cabometyx was based on results that showed that the drug was associated with improved outcomes in patients with radioactive iodine–refractory locally advanced or metastatic differentiated thyroid cancer.